EUCTR2005-003775-21-GB进行中（未招募）1 期
Effects of atorvastatin on microcirculatory endothelial function in patients with systemic sclerosis - Atorvastatin in systemic sclerosis
Salford Royal Hospitals NHS Trust0 个研究点目标入组 36 人开始时间: 2005年11月10日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1. A diagnosis of systemic sclerosis
- •2. Age > 18 and < 75 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Age < 18 or > 75 years
- •2. Pregnancy or breast feeding
- •3. Other contraindications to statin therapy (hypersensitivity, active liver disease, unexplained persistent elevations of serum transaminases).
研究者
相似试验
已完成
2 期
Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse SclerodermaSclerodermaNCT02370784Robyn T. Domsic, MD, MPH24
已完成
不适用
Atorvastatin and endothelial function in systemic lupus erythematosus (SLE) patientsSystemic lupus erythematosus (SLE)Musculoskeletal DiseasesSystemic lupus erythematosusISRCTN19073445State of São Paulo Research Foundation (FAPESP) (Brazil)88
招募中
不适用
A clinical trial to find out the effect of Atorvastatin on dilatation of forearm blood vessel,in patients with Systemic Sclerosis.CTRI/2020/07/026894Intra Mural Research Fund
招募中
2 期
The effects of atorvastatin consumption in patients with type 2 diabetesType 2 diabetes.Type 2 diabetes mellitusIRCT20231122060137N1Kerman University of Medical Sciences60
已完成
4 期
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk PatientsHMG-CoA Reductase Inhibitor ToxicityOxidative StressEndothelial DysfunctionAtherosclerosisCoronary Artery DiseaseNCT01013103Hippocration General Hospital72